Literature DB >> 25726920

Motivational interviewing for smoking cessation.

Nicola Lindson-Hawley1, Tom P Thompson, Rachna Begh.   

Abstract

BACKGROUND: Motivational Interviewing (MI) is a directive patient-centred style of counselling, designed to help people to explore and resolve ambivalence about behaviour change. It was developed as a treatment for alcohol abuse, but may help people to a make a successful attempt to quit smoking.
OBJECTIVES: To determine whether or not motivational interviewing (MI) promotes smoking cessation. SEARCH
METHODS: We searched the Cochrane Tobacco Addiction Group Specialized Register for studies using the term motivat* NEAR2 (interview* OR enhanc* OR session* OR counsel* OR practi* OR behav*) in the title or abstract, or motivation* as a keyword. Date of the most recent search: August 2014. SELECTION CRITERIA: Randomized controlled trials in which motivational interviewing or its variants were offered to tobacco users to assist cessation. DATA COLLECTION AND ANALYSIS: We extracted data in duplicate. The main outcome measure was abstinence from smoking after at least six months follow-up. We used the most rigorous definition of abstinence in each trial, and biochemically validated rates where available. We counted participants lost to follow-up as continuing smoking or relapsed. We performed meta-analysis using a fixed-effect Mantel-Haenszel model. MAIN
RESULTS: We identified 28 studies published between 1997 and 2014, involving over 16,000 participants. MI was conducted in one to six sessions, with the duration of each session ranging from 10 to 60 minutes. Interventions were delivered by primary care physicians, hospital clinicians, nurses or counsellors. Our meta-analysis of MI versus brief advice or usual care yielded a modest but significant increase in quitting (risk ratio (RR) 1.26; 95% confidence interval (CI) 1.16 to 1.36; 28 studies; N = 16,803). Subgroup analyses found that MI delivered by primary care physicians resulted in an RR of 3.49 (95% CI 1.53 to 7.94; 2 trials; N = 736). When delivered by counsellors the RR was smaller (1.25; 95% CI 1.15 to 1.63; 22 trials; N = 13,593) but MI still resulted in higher quit rates than brief advice or usual care. When we compared MI interventions conducted through shorter sessions (less than 20 minutes per session) to controls, this resulted in an RR of 1.69 (95% CI 1.34 to 2.12; 9 trials; N = 3651). Single-session treatments might increase the likelihood of quitting over multiple sessions, but both regimens produced positive outcomes. Evidence is unclear at present on the optimal number of follow-up calls.There was variation across the trials in treatment fidelity. All trials used some variant of motivational interviewing. Critical details in how it was modified for the particular study population, the training of therapists and the content of the counselling were sometimes lacking from trial reports. AUTHORS'
CONCLUSIONS: Motivational interviewing may assist people to quit smoking. However, the results should be interpreted with caution, due to variations in study quality, treatment fidelity, between-study heterogeneity and the possibility of publication or selective reporting bias.

Entities:  

Mesh:

Year:  2015        PMID: 25726920     DOI: 10.1002/14651858.CD006936.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  85 in total

1.  Smokers who are unmotivated to quit and have a child with asthma are more likely to quit with intensive motivational interviewing and repeated biomarker feedback.

Authors:  Belinda Borrelli; Romano Endrighi; S Katharine Hammond; Shira Dunsiger
Journal:  J Consult Clin Psychol       Date:  2017-11

Review 2.  Individual behavioural counselling for smoking cessation.

Authors:  Tim Lancaster; Lindsay F Stead
Journal:  Cochrane Database Syst Rev       Date:  2017-03-31

Review 3.  Smoking resumption after heart or lung transplantation: a systematic review and suggestions for screening and management.

Authors:  Patrick Hofmann; Christian Benden; Malcolm Kohler; Macé M Schuurmans
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

Review 4.  Innovative approaches to support smoking cessation for individuals with mental illness and co-occurring substance use disorders.

Authors:  Smita Das; Judith J Prochaska
Journal:  Expert Rev Respir Med       Date:  2017-08-09       Impact factor: 3.772

5.  Impact of group motivational interviewing on enhancing treatment engagement for homeless Veterans with nicotine dependence and other substance use disorders: A pilot investigation.

Authors:  Elizabeth J Santa Ana; Steven D LaRowe; Kent Armeson; Kayla E Lamb; Karen Hartwell
Journal:  Am J Addict       Date:  2016-09-02

Review 6.  Achieving Smoking Cessation Among Persons with Opioid Use Disorder.

Authors:  Cynthia Vlad; Julia H Arnsten; Shadi Nahvi
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

7.  Randomized Controlled Trial of Motivational Interviewing to Support Breastfeeding Among Appalachian Women.

Authors:  Sarah H Addicks; Daniel W McNeil
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2019-06-07

8.  Planning a Change Easily (PACE): A randomized controlled trial for smokers who are not ready to quit.

Authors:  Francisco I Salgado García; Karen J Derefinko; Zoran Bursac; Sarah Hand; Robert C Klesges
Journal:  Contemp Clin Trials       Date:  2018-03-13       Impact factor: 2.226

9.  Motivational, reduction and usual care interventions for smokers who are not ready to quit: a randomized controlled trial.

Authors:  Elias M Klemperer; John R Hughes; Laura J Solomon; Peter W Callas; James R Fingar
Journal:  Addiction       Date:  2016-10-05       Impact factor: 6.526

10.  Training Primary Care Physicians to Employ Self-Efficacy-Enhancing Interviewing Techniques: Randomized Controlled Trial of a Standardized Patient Intervention.

Authors:  Anthony Jerant; Richard L Kravitz; Daniel Tancredi; Debora A Paterniti; Lynda White; Lynn Baker-Nauman; Dionne Evans-Dean; Chloe Villarreal; Lori Ried; Andrew Hudnut; Peter Franks
Journal:  J Gen Intern Med       Date:  2016-03-08       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.